Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical, clinical, behavioral and social sciences research, to conduct small research projects within the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), or the National Human Genome Research Institute (NHGRI), or the National Institute of Biomedical Imaging and Bioengineering (NIBIB). This funding opportunity will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition of new and early stage investigators to research independence. In addition, this funding opportunity supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. New investigators at the time of award under this NOFO will have had less than $125,000 direct costs of combined, active research funding (excluding NIH SuRE-First awards and training and career awards).
Funding Opportunity Details
PAR-25-097
None
NOTE: The NIDDK does not co-sponsor the NIH Exploratory Developmental Research Grant Program (Parent R21). The NIDDK will continue to accept R21 applications submitted in response to targeted NIDDK solicitations.
Key Dates
1/16/2025
Not Applicable
February 16, 2025; June 16, 2025; October 15, 2025